AMP-Activated Protein Kinase Signalling.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
12 Feb 2019
Historique:
received: 29 01 2019
revised: 04 02 2019
accepted: 04 02 2019
entrez: 15 2 2019
pubmed: 15 2 2019
medline: 4 6 2019
Statut: epublish

Résumé

AMP-activated protein kinase (AMPK) regulates energy homeostasis in eukaryotic cells and organisms [...].

Identifiants

pubmed: 30759716
pii: ijms20030766
doi: 10.3390/ijms20030766
pmc: PMC6386857
pii:
doi:

Substances chimiques

AMP-Activated Protein Kinases EC 2.7.11.31

Types de publication

Editorial

Langues

eng

Sous-ensembles de citation

IM

Références

Int J Mol Sci. 2018 Apr 15;19(4):null
pubmed: 29662023
Int J Mol Sci. 2018 Jun 12;19(6):null
pubmed: 29895790
Int J Mol Sci. 2018 Jun 19;19(6):null
pubmed: 29921805
Int J Mol Sci. 2018 Jul 13;19(7):null
pubmed: 30011834
Int J Mol Sci. 2018 Aug 15;19(8):null
pubmed: 30111748
Int J Mol Sci. 2018 Sep 13;19(9):null
pubmed: 30217073
Int J Mol Sci. 2018 Sep 19;19(9):null
pubmed: 30235785
Int J Mol Sci. 2018 Sep 27;19(10):null
pubmed: 30262782
Int J Mol Sci. 2018 Sep 30;19(10):null
pubmed: 30274374
Int J Mol Sci. 2018 Oct 09;19(10):null
pubmed: 30304773
Int J Mol Sci. 2018 Oct 09;19(10):null
pubmed: 30304866
Int J Mol Sci. 2018 Oct 11;19(10):null
pubmed: 30314396
Int J Mol Sci. 2018 Oct 19;19(10):null
pubmed: 30347687
Int J Mol Sci. 2018 Oct 23;19(11):null
pubmed: 30360486
Int J Mol Sci. 2018 Oct 23;19(11):null
pubmed: 30360525
Int J Mol Sci. 2018 Oct 25;19(11):null
pubmed: 30366365
Int J Mol Sci. 2018 Oct 26;19(11):null
pubmed: 30373152
Int J Mol Sci. 2018 Nov 05;19(11):null
pubmed: 30400630
Int J Mol Sci. 2018 Nov 06;19(11):null
pubmed: 30404151
Int J Mol Sci. 2018 Nov 06;19(11):null
pubmed: 30404221
Int J Mol Sci. 2018 Nov 11;19(11):null
pubmed: 30423881
Int J Mol Sci. 2018 Nov 09;19(11):null
pubmed: 30423971
Int J Mol Sci. 2018 Nov 12;19(11):null
pubmed: 30424476
Int J Mol Sci. 2018 Nov 22;19(12):null
pubmed: 30467274
Int J Mol Sci. 2018 Nov 29;19(12):null
pubmed: 30501132
Int J Mol Sci. 2018 Dec 05;19(12):null
pubmed: 30563079

Auteurs

Dietbert Neumann (D)

Department of Pathology, CARIM School for Cardiovascular Diseases, Faculty of Health, Medicine and Life Sciences, Maastricht University, 6200 MD Maastricht, The Netherlands. d.neumann@maastrichtuniversity.nl.

Benoit Viollet (B)

INSERM U1016, Institut Cochin, Department of Endocrinology, Metabolism and Diabetes (EMD), 24 rue du faubourg Saint-Jacques, 75014 Paris, France. benoit.viollet@inserm.fr.
CNRS, UMR8104, 75014 Paris, France. benoit.viollet@inserm.fr.
Université Paris Descartes, Sorbonne Paris Cité, 75014 Paris, France. benoit.viollet@inserm.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH